A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Recruiting

Vedolizumab & TofacitinibA Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Sponsor:

Takeda

Code:

NCT06095128

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Vedolizumab

Tofacitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-18. This information was provided to ClinicalTrials.gov by Takeda on 2025-11-10.